Syntax Bio
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine
$14.4MSeries A+
Role not disclosedDA
Draper Associates
Activity from announced rounds
Activity in this selectionUnited States · Jun 30, 2026 · Jun 1, 2026
Draper Associates is a global venture firm investing in AI, robotics, blockchain, healthcare, biotechnology, aerospace and other emerging technologies.
Its blockchain thesis includes decentralised finance, tokenised assets and decentralised infrastructure. In healthcare, it focuses on technologies such as AI diagnostics, regenerative medicine and neurotechnology that can improve prevention and healthy lifespan.
The firm also backs automation and human-machine collaboration, alongside space technologies. Founders can submit a pitch directly through its website, which also provides an AI pitch-coaching tool.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $29.4M 2 disclosed · full round size, not this investor’s share